Get the Stockscreener App
0.4734
9.01%
-0.0469
After Hours:
.46
-0.0134
-2.83%
Autonomix Medical Inc stock is traded at $0.4734, with a volume of 603.39K.
It is down -9.01% in the last 24 hours and down -25.09% over the past month.
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
See More
Previous Close:
$0.5203
Open:
$0.51
24h Volume:
603.39K
Relative Volume:
0.08
Market Cap:
$3.27M
Revenue:
-
Net Income/Loss:
$-12.05M
P/E Ratio:
-0.0753
EPS:
-6.2848
Net Cash Flow:
$-10.14M
1W Performance:
-7.58%
1M Performance:
-25.09%
6M Performance:
-68.65%
1Y Performance:
-83.45%
1-Day Range:
$0.4677
$0.51
1-Week Range:
$0.465
$0.5385
52-Week Range:
$0.465
$3.325
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
0.4734 | 3.59M | 0 | -12.05M | -10.14M | -6.2848 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Autonomix Medical Inc Stock (AMIX) Latest News
Will Autonomix Medical Inc stock hit new highs in YEARJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - baoquankhu1.vn
Autonomix Medical receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Australia
Autonomix Medical receives Nasdaq notice for minimum bid price deficiency - Investing.com India
Autonomix Medical Receives Nasdaq Minimum Bid Price Notice - TipRanks
Autonomix Medical Received Notice of Noncompliance - TradingView — Track All Markets
Gainers Report: Can Autonomix Medical Inc outperform under higher oil pricesEarnings Summary Report & Consistent Return Investment Signals - baoquankhu1.vn
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Increases By 1,052.8% - Defense World
Published on: 2026-01-13 18:33:29 - Bộ Nội Vụ
Autonomix reports pain relief in pancreatic cancer patients across stages By Investing.com - Investing.com Nigeria
Why Autonomix Medical Inc. stock remains on buy listsMarket Risk Summary & Verified Trade Idea Suggestions - Улправда
Autonomix (AMIX) Stock: Clinical Subgroup Analysis Supports Potential Palliative Impact of RF Denervation - parameter.io
Autonomix Medical Granted Patent for Cardiac Tissue Treatment - Medical Product Outsourcing
Autonomix Medical reports promising pain relief in pancreatic cancer - TipRanks
Autonomix reports pain relief in pancreatic cancer patients across stages - Investing.com
Autonomix Medical stock soars after pain relief data in pancreatic cancer - Investing.com Nigeria
Autonomix Medical, Inc. Announces New Clinical Data on Pancreatic Cancer Pain Relief - TradingView — Track All Markets
Autonomix Medical stock soars after pain relief data in pancreatic cancer By Investing.com - Investing.com Canada
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - The Manila Times
Autonomix Medical Reports Positive Subgroup Analysis on Pain Relief in Pancreatic Cancer Patients Across All Disease Stages - Quiver Quantitative
New procedure helps ease severe pancreatic cancer pain fast - Stock Titan
Autonomix Medical announces pricing of $5M private placement - MSN
Can Autonomix Medical Inc. stock hit analyst price targets2025 Key Lessons & Proven Capital Preservation Tips - Улправда
How Autonomix Medical Inc. stock reacts to bond yieldsMarket Activity Summary & Weekly High Potential Stock Alerts - Улправда
Will Autonomix Medical Inc. stock outperform value stocks2025 Performance Recap & Expert Curated Trade Ideas - Улправда
Why Autonomix Medical Inc. stock remains resilientJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Улправда
Take Profit: Will Autonomix Medical Inc. stock attract ESG investorsMarket Trend Summary & Precise Swing Trade Alerts - Улправда
Growth Recap: How Autonomix Medical Inc stock reacts to bond yields2025 Volume Leaders & AI Powered Market Trend Analysis - moha.gov.vn
Was Autonomix Medical Inc (AMIX)’s session last reading good? - uspostnews.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Autonomix granted European patent on nerve-targeted therapies technology - MSN
Autonomix secures European patent for cardiac tissue treatment tech By Investing.com - Investing.com Nigeria
Silver Rises Sharply; Chicago PMI Surges In December - Benzinga
Autonomix Medical (AMIX) Stock: Skyrockets Following Major Patent Approval - parameter.io
Autonomix secures European patent for cardiac tissue treatment tech - Investing.com
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - The Manila Times
Autonomix Medical, Inc. Strengthens Global IP Portfolio with New European Patent for Advanced Cardiac Treatment Technologies - Quiver Quantitative
Autonomix Medical, Inc. Granted European Patent on Platform - GlobeNewswire
Autonomix Medical (NASDAQ:AMIX) Trading 1.7% Higher – Still a Buy? - Defense World
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - 富途牛牛
Autonomix Medical, Inc. CEO Discusses Key Strategic Priorities in Recent Virtual Investor Connect Segment - Quiver Quantitative
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding - GlobeNewswire
Nerve-treatment company maps uses beyond pancreatic cancer - Stock Titan
Can Autonomix Medical Inc stock resist sector downturnsTrade Analysis Report & AI Driven Price Predictions - moha.gov.vn
Portfolio Shifts: Why Autonomix Medical Inc stock appeals to analysts2025 Key Highlights & Free Community Consensus Stock Picks - moha.gov.vn
Autonomix to present pancreatic cancer pain treatment data at ASCO By Investing.com - Investing.com Australia
Is Autonomix Medical Inc. stock cheap at current valuationMarket Movers & Risk Managed Investment Entry Signals - DonanımHaber
How Autonomix Medical Inc. stock trades during market volatilityJuly 2025 PreEarnings & Consistent Profit Alerts - Улправда
Autonomix to present pancreatic cancer pain treatment data at ASCO - Investing.com
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - The Manila Times
Autonomix Medical, Inc. to Present Research on Pain Mitigation in Pancreatic Adenocarcinoma at 2026 ASCO Gastrointestinal Cancers Symposium - Quiver Quantitative
Autonomix Medical Inc Stock (AMIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
1.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):